R2

Mpox Is Settling In

One in four Korean adults met MASLD criteria. Four everyday habits were linked to 29% lower odds

Hantavirus Tested Europe’s Borders

Myositis Finally Gets a Targeted Signal

Bayer’s ESC 2026 programme puts the heart-kidney axis centre stage. Disease silos are starting to look obsolete

MS Prevention Is Still Too Passive

Europe Has The Mosquitoes. Not The Tools.

Four in five young adults in an urban U.S. cohort had CKM risk factors. Cardiovascular prevention is arriving too late

West Nile Is Now In 77 European Areas. Blood Safety Must Move With It.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
